| Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment (NCT05890352) | SWOG Cancer Research Network | 2023-09-26 |
| A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema (NCT06007677) | Astria Therapeutics, Inc. | 2023-09-26 |
| Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis (NCT04448106) | Celltex Therapeutics Corporation | 2023-09-25 |
| Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence (NCT06120127) | Fudan University | 2023-09-25 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants (NCT06060977) | Inmagene LLC | 2023-09-25 |
| Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (NCT05928806) | Michael B. Atkins, MD | 2023-09-25 |
| Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study (NCT06083701) | Peking Union Medical College Hospital | 2023-09-25 |
| Fisetin to Improve Vascular Function in Older Adults (NCT06133634) | University of Colorado, Boulder | 2023-09-25 |
| Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria (NCT06077773) | Escient Pharmaceuticals, Inc | 2023-09-25 |
| Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC (NCT06037655) | The First Affiliated Hospital with Nanjing Medical University | 2023-09-25 |
| Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI (NCT05845749) | University of California, San Francisco | 2023-09-25 |
| A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer (NCT06147570) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-09-25 |
| Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study (NCT05900219) | Shanghai Kechow Pharma, Inc. | 2023-09-24 |
| Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients (NCT06147986) | Ever Supreme Bio Technology Co., Ltd. | 2023-09-24 |
| Cryoablation+Ipilimumab+Nivolumab in Melanoma (NCT05779423) | Massachusetts General Hospital | 2023-09-23 |
| Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease. (NCT07708987) | Tata Memorial Centre | 2023-09-23 |
| FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach (NCT06071312) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2023-09-23 |
| Efficacy and Safety of Tocilizumab for TAO (NCT06087731) | Sun Yat-sen University | 2023-09-23 |
| Spesolimab in Pyoderma Gangrenosum (NCT06092216) | Icahn School of Medicine at Mount Sinai | 2023-09-23 |
| Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery (NCT06262581) | Sun Yat-sen University | 2023-09-23 |
| A Study YL201 in Patients With Selected Advanced Solid Tumors (NCT06057922) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2023-09-22 |
| Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC (NCT06023758) | Peking University | 2023-09-22 |
| To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis (NCT06061471) | Akeso | 2023-09-22 |
| The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure (NCT05989958) | Hexaell Biotech Co., Ltd. | 2023-09-22 |
| A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy (NCT05923866) | Ono Pharmaceutical Co., Ltd. | 2023-09-22 |
| Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons (NCT05683834) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-09-22 |
| Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management (NCT05664815) | Centre Hospitalier Universitaire de Besancon | 2023-09-22 |
| RY_SW01 Cell Injection Therapy in Systemic Sclerosis (NCT06058091) | Jiangsu Renocell Biotech Company | 2023-09-22 |
| Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD). (NCT06051448) | Children's Hospital of Philadelphia | 2023-09-22 |
| Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial (NCT05554380) | National Cancer Institute (NCI) | 2023-09-22 |
| Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer (NCT06058988) | Memorial Sloan Kettering Cancer Center | 2023-09-22 |
| JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus (NCT05967520) | Jemincare | 2023-09-21 |
| A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines (NCT05988203) | BioNTech SE | 2023-09-21 |
| Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC) (NCT05822752) | AbbVie | 2023-09-21 |
| A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults (NCT05736835) | CyanVac LLC | 2023-09-21 |
| A Study of AT-02 in Subjects With Systemic Amyloidosis. (NCT05951049) | Attralus, Inc. | 2023-09-21 |
| A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma (NCT06057948) | Memorial Sloan Kettering Cancer Center | 2023-09-21 |
| A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity (NCT06037252) | Eli Lilly and Company | 2023-09-21 |
| BTZ-043 Dose Evaluation in Combination and Selection (NCT05926466) | Michael Hoelscher | 2023-09-21 |
| PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor (NCT05801237) | Shanghai HyaMab Biotech Co.,Ltd. | 2023-09-21 |
| Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy (NCT05794139) | NMD Pharma A/S | 2023-09-21 |
| Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia (NCT05863234) | Hiroshima University Hospital | 2023-09-21 |
| Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome (NCT06101147) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-09-21 |
| A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma (NCT06057935) | Memorial Sloan Kettering Cancer Center | 2023-09-21 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A (NCT05987449) | Hoffmann-La Roche | 2023-09-21 |
| Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia (NCT06239207) | Services Hospital, Lahore | 2023-09-21 |
| Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma (NCT05849610) | PETHEMA Foundation | 2023-09-21 |
| A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma (NCT06018129) | Genmab | 2023-09-21 |
| An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007 (NCT06075537) | Denali Therapeutics Inc. | 2023-09-20 |
| Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques (NCT03382249) | First Affiliated Hospital of Harbin Medical University | 2023-09-20 |
| Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial (NCT06063057) | Sinovac Biotech Co., Ltd | 2023-09-20 |
| Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy (NCT05978648) | wang shusen | 2023-09-20 |
| Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer (NCT05535218) | Claudia Guerrieri | 2023-09-20 |
| Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer (NCT06138028) | Qingdao Central Hospital | 2023-09-20 |
| A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer. (NCT05917470) | Oncternal Therapeutics, Inc | 2023-09-20 |
| Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics (NCT06077539) | Cairo University | 2023-09-20 |
| Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) (NCT06022757) | Evopoint Biosciences Inc. | 2023-09-20 |
| A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain (NCT05838755) | GlaxoSmithKline | 2023-09-20 |
| Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT) (NCT06621043) | Fenix Innovation Group | 2023-09-20 |
| A Study for the Treatment of Dry Eye in Postmenopausal Women (NCT06133166) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-09-20 |
| A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis (NCT05923099) | LEO Pharma | 2023-09-20 |
| MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder (NCT05709353) | University of Sydney | 2023-09-19 |
| Mesenchymal Stromal Cells for Traumatic Brain Injury (NCT06163833) | Fondazione IRCCS San Gerardo dei Tintori | 2023-09-19 |
| Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) (NCT06094101) | University Hospital Tuebingen | 2023-09-19 |
| Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases. (NCT05872347) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-09-19 |
| Vitamin C Effectiveness in Preventing Urinary Tract Infections After Gynecological Surgeries (NCT05913180) | American University of Beirut Medical Center | 2023-09-19 |
| A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC (NCT05773105) | Sun Yat-sen University | 2023-09-19 |
| Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial (NCT06125782) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-09-19 |
| Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell Transplant (NCT04932564) | Tata Memorial Centre | 2023-09-18 |
| Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT (NCT05288790) | Vanderbilt University Medical Center | 2023-09-18 |
| Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion (NCT05976646) | Virginia Commonwealth University | 2023-09-18 |
| Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients (NCT05743504) | National Taiwan University Hospital | 2023-09-18 |
| Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia (NCT06062953) | Lone Baandrup | 2023-09-18 |
| Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation (NCT06102213) | Prolacta Bioscience | 2023-09-18 |
| Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma (NCT06041724) | Fudan University | 2023-09-18 |
| GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer (NCT05998447) | Genome & Company | 2023-09-18 |
| Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation (NCT06001593) | Seoul National University Hospital | 2023-09-18 |
| Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia (NCT06036797) | Maternal and Child Health Hospital of Hubei Province | 2023-09-17 |
| The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients (NCT06036966) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-09-16 |
| Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer (NCT05714891) | Canadian Cancer Trials Group | 2023-09-15 |
| The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy (NCT06472739) | Sun Yat-sen University | 2023-09-15 |
| A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin (NCT06064006) | Novo Nordisk A/S | 2023-09-15 |
| Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients. (NCT06018688) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2023-09-15 |
| Efficacy of Adding Dexmedetomidine Versus Ibuprofen as an Adjuvant to Intraperitoneal Bupivacaine for Pain Control After Laparoscopic Gynecological Procedures (NCT06046105) | Ain Shams University | 2023-09-15 |
| NSAID Use After Robotic Partial Nephrectomy (NCT05842044) | University of Miami | 2023-09-15 |
| A Phase Ⅱ Study of Anlotinib Combined With Tislelizumab and AT in the Neoadjuvant Treatment of Triple-negative Breast Cancer (NCT04914390) | Sichuan Provincial People's Hospital | 2023-09-15 |
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) (NCT05685004) | TVAX Biomedical | 2023-09-15 |
| High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial (NCT05943691) | Shandong University | 2023-09-15 |
| The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus (NCT06159686) | Thammasat University Hospital | 2023-09-15 |
| Hepatic Artery Infusion of Adebrelimab Combined With Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma With Failure of Systemic Therapy Combined With Interventional Therapy (NCT05975463) | HuiKai Li | 2023-09-15 |
| Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer (NCT05756907) | Sonnet BioTherapeutics | 2023-09-15 |
| Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer (NCT05809895) | Novartis Pharmaceuticals | 2023-09-15 |
| Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas (NCT05745857) | University Medical Center Groningen | 2023-09-15 |
| An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors (NCT06038461) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-09-15 |
| Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (NCT05951179) | Protara Therapeutics | 2023-09-15 |
| A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833 (NCT06019559) | Kallyope Inc. | 2023-09-15 |
| Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss (NCT05821959) | Akouos, Inc. | 2023-09-15 |
| Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy (NCT05941845) | Centre Hospitalier Universitaire de Nice | 2023-09-14 |
| Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH (NCT06054815) | NeuroBo Pharmaceuticals Inc. | 2023-09-14 |
| Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) (NCT06569524) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-09-14 |